Transplantation for Patients With Chronic Lymphocytic Leukemia
Completed · Not applicable
Conditions studied: Leukemia, Lymphocytic, Chronic
In brief
To evaluate the role of high dose therapy and autologous or allogeneic hematopoietic cell transplantation for the treatment of chronic lymphocytic leukemia.
Key facts
- Study ID
- NCT00186303
- Run by
- Stanford University
- People needed
- 28
- Starts
- 1996-11-01
- Expected to finish
- 2010-03-01
- Last updated by the study team
- 2012-12-17
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.